Minerva Neurosciences Inc (NASDAQ:NERV)
| 0.3555 Delayed Data As of May 20 |  -0.0356 / -9.10%Today’s Change | 0.33 Today|||52-Week Range 3.27 | -55.62% Year-to-Date |
Latest NERV News | Press Releases
No recent news for Minerva Neurosciences Inc.
Today’s Trading
| Previous close | 0.39 |
| Today’s open | 0.38 |
| Day’s range | 0.36 - 0.38 |
| Volume | 300 |
| Average volume (3 months) | 106,325 |
| Market cap | $16.0M |
Data as of 1:24pm ET, 05/20/2022
Growth & Valuation
| Earnings growth (last year) | -2,559.37% |
| Earnings growth (this year) | +29.14% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.01 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DFFNDiffusion Pharmaceut... | +0.14 | +1.79% |
| ---- | ||
| IMRNImmuron Ltd | 0.00 | 0.00% |
| PULMPulmatrix Inc | -0.16 | -3.09% |
Data as of 2:54pm ET, 05/20/2022
Financials
| Next reporting date | August 4, 2022 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$49.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Waltham, Massachusetts |
Forecasts
